Follow
Jake Chabon
Jake Chabon
CEO/CSO, Foresight Diagnostics Inc.
Verified email at stanford.edu - Homepage
Title
Cited by
Cited by
Year
Integrated digital error suppression for improved detection of circulating tumor DNA
AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ...
Nature biotechnology 34 (5), 547-555, 2016
10432016
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
Cancer discovery 7 (12), 1394-1403, 2017
7722017
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ...
Nature communications 7 (1), 1-15, 2016
6052016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
JJ Chabon, AD Simmons, AF Lovejoy, MS Esfahani, AM Newman, ...
Nature communications 7 (1), 1-15, 2016
6052016
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
CM Blakely, TBK Watkins, W Wu, B Gini, JJ Chabon, CE McCoach, ...
Nature genetics 49 (12), 1693-1704, 2017
4782017
Integrating genomic features for non-invasive early lung cancer detection
JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ...
Nature 580 (7802), 245-251, 2020
4452020
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
F Scherer, DM Kurtz, AM Newman, H Stehr, AFM Craig, MS Esfahani, ...
Science translational medicine 8 (364), 364ra155-364ra155, 2016
4272016
Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma
DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ...
Journal of Clinical Oncology 36 (28), 2845, 2018
3802018
Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition
BY Nabet, MS Esfahani, EJ Moding, EG Hamilton, JJ Chabon, H Rizvi, ...
Cell 183 (2), 363-376. e13, 2020
2412020
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
EJ Moding, Y Liu, BY Nabet, JJ Chabon, AA Chaudhuri, AB Hui, ...
Nature Cancer 1 (2), 176-183, 2020
2352020
Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer
TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ...
Gastroenterology 158 (3), 494-505. e6, 2020
1692020
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ...
Nature biotechnology 39 (12), 1537-1547, 2021
1642021
Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates
X Qi, J Hong, L Chaves, Y Zhuang, Y Chen, D Wang, J Chabon, ...
Immunity 39 (1), 97-110, 2013
1592013
Detection and surveillance of bladder cancer using urine tumor DNA
JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ...
Cancer discovery 9 (4), 500-509, 2019
1562019
A mathematical model of ctDNA shedding predicts tumor detection size
S Avanzini, DM Kurtz, JJ Chabon, EJ Moding, SS Hori, SS Gambhir, ...
Science advances 6 (50), eabc4308, 2020
1262020
Molecular profiling of single circulating tumor cells from lung cancer patients
S Park, DJ Wong, CC Ooi, DM Kurtz, O Vermesh, A Aalipour, S Suh, ...
Proceedings of the National Academy of Sciences 113 (52), E8379-E8386, 2016
1122016
Transforming Growth Factor-β Signaling Promotes Pulmonary Hypertension Caused by Schistosoma Mansoni
BB Graham, J Chabon, L Gebreab, J Poole, E Debella, L Davis, T Tanaka, ...
Circulation 128 (12), 1354-1364, 2013
1082013
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ...
Cancer discovery 10 (12), 1826-1841, 2020
972020
Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L) 1 blockade in NSCLC
MD Hellmann, BY Nabet, H Rizvi, AA Chaudhuri, DK Wells, MPS Dunphy, ...
Clinical Cancer Research 26 (12), 2849-2858, 2020
942020
Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 2017; 7: 1394–1403. doi: 10.1158/2159-8290
AA Chaudhuri, JJ Chabon, AF Lovejoy, AM Newman, H Stehr, TD Azad, ...
CD-17-0716.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
94
The system can't perform the operation now. Try again later.
Articles 1–20